{"id":"W2140868856","doi":"10.1056/nejmoa1105185","title":"A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":2174,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Children's Hospital of Pittsburgh; University of Alabama; National Center for Research Resources; University of Pennsylvania; Seattle Children's Research Institute; Vertex Pharmaceuticals; Case Western Reserve University; Medical Center, University of Pittsburgh; Cystic Fibrosis Foundation; University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; Imperial College London; University of Washington; Cystic Fibrosis Foundation Therapeutics; National Institute for Health and Care Research; University of Alabama at Birmingham; Children's Hospital of Philadelphia","keywords":"Potentiator; Cystic fibrosis; Medicine; Ivacaftor; Cystic fibrosis transmembrane conductance regulator; Mutation; Internal medicine; Genetics; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008539537,0.0004850104,0.001432895,0.0001857992,0.0003484896,0.0003009017,0.0003266409,0.0009769003,0.001926007],"category_scores_gemma":[0.0009316244,0.0002178423,0.0006717729,0.0002091583,0.0003942592,0.00027373,0.0002203232,0.000905925,0.0002910938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003049631,"about_ca_system_score_gemma":0.0003675782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004998201,"about_ca_topic_score_gemma":0.001079842,"domain_scores_codex":[0.9997106,0.0001145798,0.00003589069,0.00004856436,0.00003714815,0.00005315663],"domain_scores_gemma":[0.9994504,0.0001669307,0.0001676472,0.00001563631,0.00002578791,0.0001736387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6696413,0.01265502,0.09818746,0.002943421,0.001578888,0.001151469,0.0002562917,0.0006072922,0.04863462,0.0002382917,0.003024814,0.1610812],"study_design_scores_gemma":[0.2549392,0.5162501,0.2099888,0.0004343875,0.002612655,0.00267783,0.0001933932,0.0008131164,0.005638495,0.0001605981,0.006248627,0.00004284093],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884318,0.009807859,0.00009934212,0.0004169954,0.00009964936,0.0002012633,0.00009074528,0.0000238822,0.0008285121],"genre_scores_gemma":[0.9957259,0.002454112,0.0004218796,0.0005472957,0.0002241045,0.000157962,0.0001751922,0.00000243037,0.000291219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001926007,"threshold_uncertainty_score":0.006443143,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009679022501706713,"score_gpt":0.2428851548663161,"score_spread":0.2332061323646094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}